David Brian Perez - Jun 1, 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Jun 1, 2025
Transactions value $
$0
Form type
4
Date filed
6/3/2025, 04:06 PM
Previous filing
May 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Perez David Brian Director 9490 NEOGENOMICS WAY, FORT MYERS /s/ Ali Olivo, Attorney-in-Fact 2025-06-03 0001765355

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $0 +12.3K +56.64% $0.00 33.9K Jun 1, 2025 Direct F1
holding NEO Common Stock 10K Jun 1, 2025 Perez Joint Revocable Trust David & Karen Perez TTEE U/A Dated 12/09/2016

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Restricted Stock Unit Options Exercise $0 -12.3K -100% $0.00 0 Jun 1, 2025 Common Stock 12.3K $0.00 Direct F2
transaction NEO Stock Option (Right to Buy) Award $0 +16.1K $0.00 16.1K Jun 1, 2025 Common Stock 16.1K $7.28 Direct
transaction NEO Restricted Stock Unit Award $0 +23.1K $0.00 23.1K Jun 1, 2025 Common Stock 23.1K $0.00 Direct F2
holding NEO Stock Option (Right to Buy) 9.73K Jun 1, 2025 Common Stock 9.73K $7.34 Direct
holding NEO Stock Option (Right to Buy) 8.35K Jun 1, 2025 Common Stock 8.35K $14.82 Direct
holding NEO Stock Option (Right to Buy) 8.67K Jun 1, 2025 Common Stock 8.67K $13.71 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted stock units that were previously reported on a Form 4.
F2 Once vested, the shares of common stock are not subject to expiration.